Related by context. All words. (Click for frequent words.) 76 recurrent glioblastoma multiforme 74 Hepatocellular Carcinoma HCC 74 relapsed MM 74 adult chronic ITP 73 dirucotide MBP# 73 CYT# potent vascular disrupting 73 Hodgkin lymphoma HL 72 de novo kidney transplant 72 chronic ITP patients 72 RRMS patients 72 thetreatment 72 Amgen Neulasta R 72 oropharyngeal candidiasis OPC 72 complement inhibitor eculizumab 72 riociguat 71 recurrent malignant glioma 71 arthritis PsA 71 metastatic bladder 71 refractory acute myeloid 71 forodesine 71 recurrent metastatic 71 relapsing multiple sclerosis 71 toenail onychomycosis 71 sorafenib tablets 71 receptor tyrosine kinase inhibitor 71 acyclovir Lauriad R 71 Temsirolimus 71 Intravenous immunoglobulin 71 biliary tract cancer 71 symptomatic BPH 71 invasive candidiasis 71 mitoxantrone plus 71 SNT MC# 70 Phase IIIb clinical 70 oral rivaroxaban 70 R entecavir 70 rALLy clinical trial 70 ACTEMRA TM 70 hyperphenylalaninemia HPA due 70 MAGE A3 ASCI 70 superficial bladder cancer 70 novel VDA molecule 70 oral FTY# 70 secondary hyperparathyroidism SHPT 70 metastatic GIST 70 Tramiprosate ALZHEMED TM 70 AA Amyloidosis 70 Gleevec imatinib 70 AGILECT R 70 psoriatic arthritis PsA 70 kidney urologic 70 treatment naïve genotype 70 indolent follicular non 70 RoACTEMRA 70 Kit CD# positive 70 induced macular edema 70 Natalizumab 70 stage IIIb IV 70 nonmetastatic 70 #mg ATC 70 metastatic gastric 70 assessing T DM1 70 Raptiva R 70 Alemtuzumab 70 Naive Patients 70 reduce serum phosphate 70 Amgen Neulasta ® 70 acute HAE attacks 70 opioid induced constipation OIC 70 refractory chronic lymphocytic 69 LymphoStat B belimumab 69 YONDELIS 69 Ribavirin causes 69 naïve HCV 69 Chronic lymphocytic leukemia 69 Cloretazine 69 esophageal candidiasis 69 INSPIRE Trial Phase III 69 unresectable stage 69 CTAP# Capsules 69 nucleotide analogue 69 relapsed leukemia 69 BRIM2 69 Ophena TM 69 Peginterferon alfa 2b 69 diarrhea predominant irritable 69 systemic anaplastic large 69 Pemetrexed 69 lenalidomide Revlimid R 69 recurrent metastatic ovarian cancer 69 Relapsing remitting MS 69 myelodysplastic myeloproliferative diseases 69 MGd 69 BARACLUDE R 69 SPRYCEL ® 69 Chronic Myelogenous Leukemia CML 69 metastatic neuroendocrine tumors 69 constipation OIC 69 chronic HBV 69 advanced metastatic renal 69 leukemia AML 69 Combination REOLYSIN R 69 Temodar ® 69 treatment naive genotype 69 Bayer HealthCare Onyx Pharmaceuticals 69 HeFH 69 papillary renal cell carcinoma 69 smoldering multiple myeloma 69 Hormone Refractory Prostate Cancer 69 Degarelix 69 Certolizumab pegol 69 recurrent NSCLC 69 Atypical Hemolytic Uremic Syndrome 69 BCG refractory carcinoma 69 alfa 2a 69 minimally symptomatic 69 chronic thromboembolic pulmonary 69 metastatic renal 69 ORENCIA ® 69 galiximab 69 pediatric malignancies 69 rheumatoid arthritis psoriatic arthritis 69 Helicobacter pylori eradication 69 Pivotal Phase III 68 either acutely decompensated 68 demonstrated antitumor activity 68 Microplasmin 68 Golimumab 68 interferon gamma 1b 68 Relapsing Remitting Multiple Sclerosis 68 chemotherapy cisplatin 68 CIMZIA TM certolizumab pegol 68 refractory metastatic colorectal cancer 68 hereditary deficiency 68 Arranon 68 phase III isavuconazole 68 phase IIb trial 68 Rilonacept 68 Aflibercept 68 metastatic colorectal carcinoma 68 haematologic 68 mRCC 68 Safinamide 68 overactive bladder syndrome 68 Aryplase 68 acetonide FA 68 targeting miR 68 relapsed multiple myeloma 68 erlotinib Tarceva ® 68 PEGINTRON TM 68 pemphigus vulgaris 68 HIV HCV coinfected 68 relapsing remitting multiple sclerosis 68 docetaxel Taxotere ® 68 advanced metastatic prostate 68 atypical Hemolytic Uremic Syndrome 68 dose escalation clinical 68 Cariprazine 68 anagrelide 68 primary immunodeficiency PI 68 ELACYT 68 Acute myeloid leukemia 68 neovascular age 68 Complicated Skin 68 systemic fungal infections 68 Daclizumab 68 ® lenalidomide 68 stage IIIB 68 oral deforolimus 68 FUSILEV enhances 68 OvaRex ® MAb 68 taxane chemotherapy 68 LHRH receptor positive 68 Raptiva ® 68 immunomodulatory therapy 68 Meets Primary Endpoint 68 r hGH 68 metastatic colorectal 68 Randomized Phase II 68 Vidaza azacitidine 68 Diabetic Macular Edema 68 refractory myeloma 68 post herpetic neuralgia PHN 68 SNT-MC#/idebenone 68 neovascular diseases 68 phase IIb clinical 68 visilizumab 68 antibody MAb 68 recurrent bladder 68 Waldenstrom macroglobulinemia 68 REMINYL ® 68 Cimzia TM 68 castrate resistant prostate cancer 68 nucleoside naive 68 recurrent genital herpes 68 Phase Ib IIa 68 allogeneic HSCT 68 ospemifene 68 methylnaltrexone bromide 68 Sprycel dasatinib 68 terlipressin 68 TEMODAL 68 STRIDE PD 67 PLX STROKE targeting 67 OHR/AVR# 67 metastatic hormone refractory 67 Gleevec imatinib mesylate 67 registrational Phase 67 Behcet uveitis 67 gastrointestinal GI motility disorders 67 Amrubicin 67 ZOLINZA 67 randomized multicenter trial 67 Accelerated Partial Breast Irradiation 67 Pivotal Clinical Trial 67 intravenous cyclophosphamide 67 resistant hormone refractory 67 chronic myeloid 67 BENLYSTA TM 67 constipation predominant irritable bowel 67 Advanced Melanoma 67 Pirfenidone 67 alvespimycin 67 systemic juvenile idiopathic 67 relapsed refractory multiple myeloma 67 FOLOTYN ® 67 paclitaxel poliglumex 67 Aplidin 67 idursulfase 67 polycythemia vera essential thrombocythemia 67 decompensated liver disease 67 mildly symptomatic 67 pain palliation 67 LymphoStat B TM 67 paroxysmal nocturnal hemoglobinuria PNH 67 non hodgkin lymphoma 67 tumors GIST 67 Aviptadil 67 MYCAMINE 67 alpha1 antitrypsin deficiency 67 subcutaneous methylnaltrexone 67 phase IIb study 67 tramiprosate Alzhemed TM 67 deCODE ProstateCancer TM 67 metaglidasen 67 Adjuvant Treatment 67 herpetic keratitis 67 metastatic renal cell 67 HCV SPRINT 67 unresectable tumors 67 Glioblastoma Multiforme GBM 67 nosocomial pneumonia NP 67 BARACLUDE ® 67 catheter occlusion 67 bone marrow reticulin deposition 67 thalidomide Thalomid 67 hepatitis C HCV 67 TAXOTERE ® 67 COPAXONE R 67 Genasense ® 67 Kepivance 67 AVASTIN 67 lintuzumab SGN 67 tiuxetan 67 retinal vein occlusion induced 67 Advanced Renal Cell 67 hormone refractory metastatic prostate 67 Wafer polifeprosan 67 recurrent glioblastoma 67 commercialize deforolimus 67 deep venous thromboses 67 ARIXTRA R 67 neuroendocrine cancers 67 PEGylated interferon beta 1a 67 Syndrome LEMS 67 secondary hyperparathyroidism 67 vinorelbine tartrate 67 Chronic lymphocytic leukemia CLL 67 alkylating agent 67 cediranib 67 Adjunctive 67 Neulasta ® 67 metastatic malignant 67 intravenous iv 67 Mg Usa 67 aerosolized AAT 67 chronic rheumatic 67 oropharyngeal candidiasis 67 budesonide foam 67 efalizumab 67 gefitinib Iressa 67 hypereosinophilic syndrome 67 fistulizing Crohn disease 67 cisplatin chemotherapy 67 Silodosin 67 achieved CCyR 67 mertansine 67 brand ciclesonide HFA 67 Vidaza ® 67 Tocilizumab 67 exocrine pancreatic insufficiency EPI 67 mg administered orally 67 herpes zoster shingles 67 multiple myeloma MM 67 non resectable metastatic 67 IBS C 67 canakinumab 67 nucleoside analog 67 NATRECOR ® 67 Tibolone 67 Granulocyte Colony Stimulating Factor 67 evaluating T DM1 67 Dacogen injection 67 Dementia Related Psychosis 67 malignant pleural mesothelioma 67 NMIBC 67 tamoxifen Nolvadex ® 67 RECORD1 67 ciprofloxacin hydrochloride 67 Sebivo 67 unresectable liver cancer 67 venous stasis ulcers 67 investigational monoclonal antibody 67 stage IIIb 67 Severe Sepsis 67 vapreotide acetate 67 HuMax EGFr 66 hepatorenal syndrome 66 Congenital Emphysema 66 placebo controlled Phase III 66 FASLODEX 66 Fludara ® 66 R vitespen 66 weekly subcutaneous injections 66 Zavesca R 66 Intravitreal injections 66 PREZISTA r 66 dasatinib Sprycel 66 recurrent glioma 66 sunitinib malate 66 Follicular Lymphoma 66 Pulmonary Arterial Hypertension PAH 66 chemosensitizer 66 Major Depressive Disorder MDD 66 Patients Treated With 66 Lupus Nephritis 66 Tavocept 66 Annamycin 66 severe oral mucositis 66 Azacitidine 66 underwent resection 66 Myelodysplastic Syndrome MDS 66 Myelofibrosis 66 Nilotinib 66 anastrazole 66 Intervention Effectiveness 66 Romiplostim 66 plus prednisone prednisolone 66 receiving XGEVA 66 Proellex TM 66 Certican 66 5 fluorouracil leucovorin 66 gastrointestinal stromal tumor GIST 66 Cutaneous T 66 dual endothelin receptor antagonist 66 R bendamustine hydrochloride 66 anthracycline taxane 66 Severe Primary IGFD 66 nonsmall cell lung cancer 66 sorafenib Nexavar 66 AKT inhibitor 66 refractory cutaneous T 66 virus HCV protease inhibitor 66 BRIM3 66 essential thrombocythemia ET 66 Azilect ® 66 Mitomycin C 66 transplantation HCT 66 formerly LymphoStat B 66 lumiliximab 66 neurogenic bladder 66 Initiates Enrollment 66 HGS ETR1 mapatumumab 66 HCV NS5B polymerase 66 hematological malignancy 66 RANK Ligand inhibitor 66 idiopathic thrombocytopenic purpura ITP 66 p# biomarker 66 unstable angina UA 66 Zavesca ® 66 evaluating tivozanib 66 blinded randomized placebo controlled 66 Bezielle 66 generation purine nucleoside 66 oral ridaforolimus 66 neuropathic pain spasticity 66 Moxifloxacin 66 acute mania 66 Relapsed Multiple Myeloma 66 gastrointestinal stromal tumors GIST 66 orally inhaled migraine 66 Syncria albiglutide 66 Chronic HCV 66 Vitrasert R 66 Xelox 66 oral prodrug 66 adriamycin 66 paclitaxel cisplatin 66 metastatic androgen independent 66 hyperplasia BPH 66 Personalized Immunotherapy 66 refractory indolent non 66 dasatinib Sprycel ® 66 Methylnaltrexone 66 Viread tenofovir disoproxil fumarate 66 Achieves Primary Endpoint 66 OncoVex 66 diabetic kidney 66 bronchogenic carcinoma 66 myocardial infarction ventricular fibrillation 66 rheumatoid arthritis osteoarthritis ankylosing 66 Roche Xeloda 66 ankylosing spondylitis AS 66 ORENCIA R 66 Sudhir Agrawal D.Phil 66 BRAF V#E mutation 66 trastuzumab Herceptin ® 66 metastatic pancreatic 66 Initiates Phase II 66 uremic pruritus 66 verteporfin 66 candidemia 66 SJIA 66 non metastatic osteosarcoma 66 psoriasis Crohn disease 66 relapsed ALL 66 Overactive Bladder 66 Dacogen decitabine 66 miconazole Lauriad ® 66 Bendamustine 66 raloxifene Evista 66 novel emulsion formulation 66 relapsed ovarian cancer 66 Neulasta R 66 oral methylnaltrexone 66 HER2 positive metastatic 66 Velcade bortezomib 66 Metastatic Colorectal Cancer 66 recurrent GBM 66 CUSTOM III 66 Adjuvant chemotherapy 66 rufinamide 66 IMiDs ® compound 66 AML MDS 66 Ozarelix 66 Prostate AdenoCarcinoma Treatment 66 MMX mesalamine 66 metastatic malignant melanoma 66 skeletal metastases 66 refractory Hodgkin 66 randomized Phase IIb 66 Vicinium TM 66 pouchitis 66 elacytarabine 66 receiving VELCADE 66 NAVISTAR R 66 advanced hepatocellular carcinoma 66 NSABP B 66 severe malignant osteopetrosis 66 Glioblastoma Multiforme 66 Systemic lupus erythematosus SLE 66 calcineurin inhibitor 66 medically refractory 66 patientswith 66 vaginal candidiasis 66 refractory colorectal cancer 66 Edge STudy 66 Noxafil 66 tuberous sclerosis TS 66 #I TM# 66 fallopian tube carcinoma 66 oral dual endothelin 66 Gleevec resistant 66 recurrent glioblastoma multiforme GBM 66 somatostatin analog 66 develop HBV reactivation 66 fallopian tube cancers 66 INTEGRILIN R 66 endocrine therapies 66 Sapacitabine 66 IMiDs ® 66 unresectable HCC 66 DPNP 66 VELCADE melphalan 66 irinotecan chemotherapy 66 Initiate Phase 66 noninfectious uveitis 66 Prospective Randomized 66 HBeAg negative 66 operable breast cancer 66 tigecycline 66 argatroban 66 MYLOTARG 66 Anthracycline 66 approved incretin mimetic 66 IMiDs 66 interferon beta therapy 66 cutaneous T 66 memantine HCl 66 cilengitide 66 multicenter Phase II 66 IMA# 66 rasagiline tablets 66 SUTENT ® 66 prospectively enrolled 66 interferon beta 1b 66 Randomized Study 66 Pegylated Interferon 66 Randomized Phase 66 Betaferon R 66 delivers fluocinolone acetonide FA 66 trial evaluating PRX# 66 CIMZIA ™ 66 Cimzia ® certolizumab pegol 66 Femara letrozole 66 monoclonal antibody conjugated 66 oral vancomycin 66 chemoradiation therapy 66 ZACTIMA 66 Progressive Multifocal Leukoencephalopathy 66 collagen vascular 66 diabetic gastroparesis 66 agalsidase alfa 66 Venous thromboembolism 66 keloid scarring 66 prostate cancer HRPC 65 adefovir dipivoxil 65 steroid refractory 65 Bronchiectasis 65 leukemia APL 65 Leukemias 65 Patients Receiving 65 BR.# 65 Hepatitis C HCV 65 Squamous 65 Systemic Lupus Erythematosus SLE 65 cisplatin gemcitabine 65 immune thrombocytopenic purpura 65 Dupuytren Contracture 65 PHX# 65 Anti VEGF 65 chronic idiopathic thrombocytopenic purpura 65 Phase Ib II 65 HCV RESPOND 2 65 steroid refractory GvHD 65 ThermoDox R 65 Tolvaptan 65 weekly intravenous infusions 65 CALGB # [002] 65 prokinetic agent 65 metastatic castration resistant 65 CIMZIA TM 65 dimensional conformal radiation 65 IV NSCLC 65 CTAP# 65 GERD migraine headaches 65 Tyrosine Kinase Inhibitors 65 evaluating mipomersen 65 primary humoral immunodeficiency 65 Exherin TM 65 MKC# MT 65 mecasermin 65 Phase #b/#a clinical 65 multivessel coronary artery 65 selective modulator 65 LEUKINE 65 sodium stibogluconate 65 Soft Tissue Sarcoma 65 Mg Uk 65 Omacetaxine 65 evaluating REVLIMID 65 GAMMAGARD 65 benign prostatic hypertrophy BPH 65 leukemia CLL 65 ritonavir boosted 65 Tasigna prolongs 65 GTC recombinant human 65 ovarian endometrial 65 combination antiretroviral therapy 65 hepatitis B HBV 65 sacral nerve stimulation 65 Non inferiority 65 PEG interferon 65 concurrent chemoradiation 65 underwent surgical resection 65 RezularTM 65 Cloretazine ® 65 gallium nitrate 65 albiglutide 65 smoldering myeloma 65 autoantibody positive 65 Evoltra ® 65 Etanercept 65 nasal calcitonin product 65 Hypoactive Sexual Desire Disorder 65 Losartan 65 Rheumatoid Arthritis RA 65 interferon ribavirin 65 ALA PDT 65 post operative ileus 65 Tectin TM 65 trastuzumab DM1 T DM1 65 peritumoral brain edema 65 antiretroviral naïve 65 adalimumab Humira 65 previously untreated follicular 65 Dupuytren Disease 65 Lambert Eaton Myasthenic 65 Idiopathic Pulmonary Fibrosis 65 Tasigna nilotinib 65 CAMMS# 65 including eniluracil ADH 65 lapatinib Tykerb 65 Bosutinib 65 Cx# [002] 65 taxane chemotherapy administered 65 Tamibarotene 65 aripiprazole Abilify 65 SIMPONI TM 65 Dalbavancin 65 valacyclovir Valtrex 65 osteoporotic compression fractures 65 anthracycline chemotherapy 65 PAOD 65 AA amyloidosis 65 Phase IIb Trial 65 cinacalcet 65 severe hypercholesterolemia 65 Xanafide 65 Epratuzumab 65 Brentuximab Vedotin SGN 65 Bucindolol 65 Mantle Cell Lymphoma 65 Tibotec Therapeutics division 65 refractory NSCLC 65 atypical hemolytic uremic syndrome 65 patients undergoing percutaneous 65 metastatic RCC 65 Fludarabine 65 headache nasopharyngitis 65 randomized controlled multicenter 65 hoFH 65 Interferon beta 1b 65 candesartan cilexetil 65 Teriflunomide 65 rheumatoid arthritis RA psoriatic 65 lymphoma CTCL 65 GW# [003] 65 refractory CTCL 65 undergoing hematopoietic stem 65 Paraplatin ® 65 Deferiprone 65 arsenic trioxide injection 65 Chronic Hepatitis B 65 recombinant tissue plasminogen 65 HQK 65 Heterozygous Familial Hypercholesterolemia 65 R lenalidomide 65 Initiate Clinical Trial 65 Neovascular Age Related Macular 65 KETEK 65 Phase Ib clinical 65 taxane resistant 65 Investigational Treatment 65 myelofibrosis polycythemia vera 65 TRIOLEX HE# APOPTONE HE# 65 protease inhibitor PI 65 Pivotal Phase 65 lexidronam injection 65 CAELYX 65 Deforolimus 65 DASISION 65 BoNTA 65 DCVax ® Brain 65 non splenectomized 65 icatibant 65 PD LID 65 Acute Myeloid Leukaemia AML 65 landmark ATHENA 65 gemcitabine Gemzar ® 65 adjuvant cisplatin 65 panitumumab Vectibix 65 EchoCRT 65 Actimmune ® 65 refractory metastatic 65 malignant ascites 65 Nexavar prescribing 65 VFEND 65 ABSSSI 65 IV Busulfex 65 Traficet EN 65 steroid refractory ulcerative 65 phase IIa 65 Ragweed Allergy 65 CATIE AD 65 finasteride Proscar 65 eosinophilic asthma 65 remission induction 65 hypercholesterolemic patients 65 paclitaxel Taxol R 65 LungAlert TM 65 pediatric Crohn disease 65 rituximab refractory follicular 65 Stage IIB 65 targeted radiotherapeutic 65 EOquin TM phase 65 Archexin 65 liposomal amphotericin B 65 aflibercept VEGF Trap 65 Vascugel 65 personalized cellular immunotherapy 65 Diamyd r 65 Oral Fingolimod 65 oral Janus kinase 65 Telithromycin 65 Budesonide foam crofelemer 65 Phase III Pivotal 65 visceral metastases 65 undergone radical prostatectomy 65 nucleotide analog 65 OMNARIS HFA 65 REBETOL combination 65 RhuDex ® 65 NeuroStar TMS Therapy 65 primary hyperparathyroidism 65 advanced medullary thyroid 65 chronic opioid 65 choroidal vasculopathy 65 CCR5 antagonist 65 Pafuramidine 65 Completes Patient Enrollment 65 Advaxis Phase 65 systemic ALCL 65 opioid induced bowel dysfunction 65 inhaled bronchodilators 65 refractory acute promyelocytic 65 mycophenolate mofetil 65 active ankylosing spondylitis 65 Malignant Melanoma 65 DEB# 65 Surgical resection 65 FluCAM arm 65 abacavir Ziagen 65 POSIDUR TM 65 phase Ib 65 AFREZZA TM 65 Nexavar sorafenib 65 metastatic HRPC 65 recombinant PSMA vaccine 65 Mitoxantrone 65 intravascular hemolysis 65 Coronary Artery Bypass Graft 65 refractory gout 65 SCIg 65 acute promyelocytic leukemia APL 65 treating cancerous tumors 65 Fingolimod 65 Hsp# Inhibitor 65 humanized interleukin 6 65 Infusion Reactions Severe 65 induce remission 65 equine osteoarthritis marketed 65 evaluating picoplatin 65 ara C 65 Eculizumab 65 chronic HCV 65 opioid naive 65 dyskinesia PD LID 65 Breast conserving 65 null responder HCV 65 PNP inhibitor 65 Nexavar tablets 65 unresectable locally advanced 65 dyslipidemia hypertension diabetes 65 anterior uveitis 65 trabectedin 65 PKC# 65 Metastatic Melanoma 65 fluoropyrimidine 65 Perforomist ™ Inhalation Solution 65 Hexvix ® 65 lupus nephritis 65 TORISEL TM 65 AVAPRO 65 humanized therapeutic 65 Irinotecan 65 REBETOL combination therapy 65 SinuNase TM 65 Motesanib 65 subcutaneous immunoglobulin 65 heavily pretreated 65 lumbar spinal stenosis LSS 65 chronic GVHD 65 BEXXAR Therapeutic Regimen 65 vidofludimus 65 colorectal liver metastases 65 Vidaza R 65 THALOMID ® 65 TTR amyloidosis 65 Zavesca r 65 secondary amenorrhea 65 fusion enhancers 65 Granted Orphan Drug 65 AZILECT ® 65 diabetic neuropathic pain 65 adjuvant colon cancer 65 maximally tolerated lipid lowering 65 refractory ovarian cancer 65 allogeneic bone marrow 65 Isentress raltegravir 65 refractory chronic myeloid 64 sapropterin dihydrochloride Tablets 64 biliary strictures produced 64 immunocompetent adults 64 Peginterferon 64 Xeloda ® 64 Torisel 64 Stereotactic Body Radiation Therapy 64 beta 1a 64 glucocorticoid induced osteoporosis 64 Xeloda capecitabine 64 proliferative retinopathy 64 www.soliris.net 64 INVEGA ® 64 alefacept 64 Menaflex implanted 64 epithelial ovarian 64 chronic hepatitis B. 64 Telbivudine 64 de novo AML 64 SomatoKine 64 Myocet 64 latent tuberculosis infection 64 Tarceva TM 64 pyridostigmine 64 GRNOPC1 contains 64 recurrent colorectal cancer 64 phase III ACCLAIM 64 Proxinium TM 64 R sorafenib tablets 64 Acute Promyelocytic Leukemia 64 AIR CF1 64 BENLYSTA ® 64 primary hypercholesterolemia 64 Albuferon TM 64 pulmonary hypertension PH 64 3D conformal radiation 64 Octreolin 64 Pertuzumab 64 UPLYSO 64 ano genital warts 64 acyclovir Lauriad ® 64 Improves Outcomes 64 TORISEL 64 leukemia lymphoma multiple myeloma 64 Catena ® 64 briakinumab 64 candidates Azedra TM 64 hypercholesterolaemia 64 lomitapide 64 included exfoliative dermatitis 64 pregabalin Lyrica 64 CINQUIL 64 HIV coinfected 64 invasive aspergillosis 64 interstitial cystitis IC 64 advanced carcinoid 64 anti inflammatory NSAID 64 dose escalation phase 64 Intravenous CP 64 refractory CLL 64 Sutent sunitinib 64 hepatitis C genotype 64 Nitazoxanide 64 Cabazitaxel 64 cirrhotic CHC monoinfected patients 64 YONDELIS R 64 neutropenia dehydration dyspnea 64 phase IIa clinical 64 Metastatic Prostate Cancer 64 basal cell carcinoma BCC 64 TG MV 64 TAXOTERE R 64 membranous nephritis 64 colorectal adenoma 64 HBV infections 64 ceftazidime 64 Glatiramer Acetate 64 SUPPRELIN R LA 64 cytomegalovirus infection 64 Fondaparinux 64 Benign Prostatic Hyperplasia 64 lupus erythematosus 64 oxypurinol 64 Malignant Glioma 64 Bevacizumab Avastin 64 Cell Lymphoma CTCL 64 oral clodronate 64 EGFR TKI 64 omega interferon 64 hormone LHRH antagonist 64 humanised monoclonal antibody 64 atherothrombotic events 64 induced anemia 64 MKC# MKC# PP 64 Valcyte tablets 64 ARIXTRA 64 anthracyclines taxanes 64 vitreoretinal disorders 64 deCODE AF TM 64 relapsed mantle 64 cetrorelix pamoate 64 Chronic Hepatitis C 64 Hepatocellular Carcinoma 64 cell carcinoma RCC 64 rhIGF-I/rhIGFBP-3 64 IMPACT DCM 64 Dual Opioid 64 myelofibrosis MF 64 Sezary syndrome 64 compound INCB# 64 Telintra 64 Jevtana 64 pegylated interferon peg IFN 64 osteoporotic vertebral compression fractures 64 Gemzar gemcitabine 64 debilitating complication 64 PRTX 64 rFVIIa 64 Diabetic Macular Edema DME 64 Zemplar Capsules 64 clinically localized prostate 64 CLARITY study 64 ancrod 64 R Saizen R 64 Juvenile Idiopathic Arthritis 64 BrachySil TM 64 oral antidiabetic medication 64 ER CHOP 64 acute GvHD 64 mycosis fungoides 64 Acute Renal Failure 64 Newly Diagnosed Multiple Myeloma 64 imexon 64 docetaxel Taxotere R 64 LNG IUS 64 PORxin TM platforms 64 prulifloxacin 64 receptor inhibitor 64 microbiologically evaluable 64 opioid tolerant adult 64 placebo controlled Phase 64 Glycopyrrolate 64 bleeding pallor 64 Campath alemtuzumab 64 IAP inhibitor 64 Inhaled nitric oxide 64 pediatric acute lymphoblastic 64 KRAS mutations occur 64 Mycophenolate Mofetil 64 Laquinimod 64 Dasatinib 64 morphometric vertebral fractures 64 low dose cytarabine 64 Pegloticase 64 Clolar ® 64 pelvic malignancies 64 vascular occlusive diseases 64 superficial basal cell carcinoma 64 ViaDerm hPTH #-# 64 Fabry Disease 64 Fibrillex TM 64 Perifosine KRX 64 G#DT 64 dexamethasone Decadron 64 GnRH agonist 64 PSMA ADC 64 COPEGUS R 64 Clevudine 64 CONBRIZA 64 metastatic kidney 64 BCIRG 64 radiation chemoradiation 64 refractory angina 64 hypervascular tumors 64 induce orthostatic hypotension 64 Morquio 64 postmenopausal osteoporotic women 64 Val HeFT